Biogen has agreed to buy UK-based gene therapy ... is caused by loss of function in the CHM which encodes the Rab escort protein -1 (REP-1), which plays a role in intracellular protein trafficking.

Leucine-rich repeat and immunoglobulin-like domain-containing protein 1 (LINGO-1), which was discovered by Biogen, 16 suppresses oligodendrocyte differentiation, axonal regeneration, and neuronal ...

In the announcement accompanying the trial results, Stephanie Fradette, head of the neuromuscular development unit at Biogen said: “While BIIB105 lowered ATXN2 protein, it did not reduce ...

Biogen Idec Inc. (BIIB) and Biovitrum AB (BIOVY, BVT.SK) said they will move ahead in testing their protein treatment for a type of hemophilia after it was well tolerated in an earlier study.